Pazoo, Inc.

Equities

PZOO

US70454Q3048

Healthcare Facilities & Services

Market Closed - OTC Markets Other stock markets 03:38:28 2024-04-30 pm EDT			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

2022	Mark Sarna entered into a Letter of Intent to acquire a 20% stake in MA & Associates, LLC from Pazoo, Inc. for $0.995747 million.	CI
2020	An unknown buyer acquired an additional 10% stake in MA & Associates, LLC from Pazoo, Inc. for $0.23 million.	CI

Pazoo, Inc. Announces Board Changes

July 23, 2012 at 01:55 pm EDT

Pazoo, Inc. announced that on July 18, 2012, David M. Cunic stepped down as Chairman of the Board of Directors and Steve Basloe, President of the Company, assumed the post of Chairman of the Board of Directors.

Latest news about Pazoo, Inc.

Mark Sarna entered into a Letter of Intent to acquire a 20% stake in MA & Associates, LLC from Pazoo, Inc. for $0.995747 million.	22-10-27	CI
An unknown buyer acquired an additional 10% stake in MA & Associates, LLC from Pazoo, Inc. for $0.23 million.	20-09-09	CI
An undisclosed buyer completed the acquisition of 70% membership interests in MA & Associates LLC from Pazoo, Inc. (OTCPK : PZOO).	17-12-30	CI
An undisclosed buyer entered into an agreement to acquire 70% membership interests in MA & Associates LLC from Pazoo, Inc. (OTCPK : PZOO) for $1.5 million.	17-11-29	CI
Pazoo, Inc. Announces Executive Changes	17-09-15	CI
Pazoo, Inc. cancelled the transaction announced on April 4, 2014	17-04-03	CI
Pazoo, Inc Implements New Validating of Testing	16-07-14	CI
Industrial Hemp and Medical Marijuana Consulting Company Signs Agreement with Pazoo	16-06-18	CI
Pazoo, Inc. will Change its Ticker to PZOO from PZOOD	16-04-26	CI
Pazoo, Inc. will Change its Ticker to PZOO from PZOO.D	16-03-30	CI
Pazoo, Inc. Receives Second Six Figure Loan from Two Individual Investors	16-03-15	CI
Pazoo Begins Generating Consulting Based Revenue with the Signing of Operational Advisory Agreement for Denver Colorado Testing Lab	15-11-09	CI
Pazoo, Inc. Signs Distribution Agreement with Pure Grow Systems, LLC	15-07-09	CI
Pazoo, Inc. acquired the remaining 60% stake in MA & Associates, LLC from Ben Bingham, Antonio Del Hierro and David Lieberthal.	15-06-24	CI
Pazoo Seeks Acquisitions	15-06-12	CI
Pazoo Forms New Wholly-Owned Subsidiary, CannabisKing Distribution LLC for the Sale and Distribution of Non-Controlled Hemp Related Products	15-05-29	CI
Pazoo, Inc. Announces Management Changes	15-05-14	CI
Pazoo, Inc. Auditor Raises 'Going Concern' Doubt	15-05-13	CI
Pazoo, Inc. Announces Creation of the MA Marketing and Sales Division; Hires Michael A. Tulimero as Head of MA Marketing and Sales Division	15-04-13	CI
Pazoo, Inc. Adds to Management Team and Expands Board of Directors from 3 to 5 Members	15-02-03	CI
Pazoo Signs Online Marketing Agreement with MobileSeed LLC	14-10-14	CI
Pazoo, Inc. Announces Resignation of Gregory C. Jung as Chief Financial Officer and Director	14-06-27	CI
Pazoo Partners with Maximum Harvest LLC Adding Cutting Edge Advertising Technology	14-06-26	CI
Pazoo, Inc. Will Publish 'Cannabis Authority' Medical Marijuana Online Magazine	14-06-03	CI
Pazoo, Inc. announced that it expects to receive $1 million in funding.	14-05-02	CI

Chart Pazoo, Inc.

Duration

Period

More charts

Company Profile

Pazoo, Inc. is a health and wellness company. The Company is engaged in providing infrastructure and analytical services to legally authorized distributors and producers of organic medicines and to regulators tracking their operations. Its line of business relating to and revolving around the cannabis industry. It holds an interest in MA & Associates LLC, a testing lab providing laboratory testing of cannabis.

Sector

Healthcare Facilities & Services

More about the company

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
PAZOO, INC.	-.--%	2.69K
SONIC HEALTHCARE LIMITED	-16.99%	8.67B
RADNET, INC.	+65.23%	4.25B
DR. LAL PATHLABS LIMITED	-1.10%	2.51B
SYNLAB AG	-10.68%	2.47B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-41.76%	2.25B
NEOGENOMICS, INC.	-8.53%	1.91B
FLEURY S.A.	-19.29%	1.56B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-39.61%	1.19B
METROPOLIS HEALTHCARE LIMITED	+9.54%	1.15B

Medical & Diagnostic Laboratories